IP Library Granted Patent US 11,141,482
Granted Patent B2
US 11,141,482 · App. 16/678,550 · Granted Oct 12, 2021

Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease

Inventors: Remigio Piergallini (A.P., IT); Nikolaos Loupis (Athens, GR)
Assignee: KLOX TECHNOLOGIES INC.
A61K41/0057A61K8/38A61K8/494A61K8/498A61K8/602A61K8/735A61K8/97A61K9/006A61K31/327A61K31/4166A61K31/7008A61K31/728A61K33/40A61K41/008A61K41/0038A61K41/0042A61K45/06A61N5/062A61N5/0603A61N5/0624A61Q11/00A61Q17/005A61N2005/0606A61N2005/0652A61N2005/0663
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,141,482
App. No.
16/678,550
Granted
Oct 12, 2021
Kind
B2
Abstract

The present document describes methods of use of photo activated compositions for oral disinfection and/or treatments which comprise at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmacologically acceptable carrier.

Claims (18)

1. A method of treating an oral disease, comprising:

a) applying a composition comprising at least one oxidant, and fluorescein or a fluorescein derivative to an oral tissue; and

b) applying actinic light having an emission wavelength between about 400 nm and 700 nm to said composition to photoexcite fluorescein or the fluorescein derivative, thereby treating said oral disease;

wherein said oral disease is selected from oral thrush, lichen planus, oral mucositis, oral submucous fibrosis, and glossitis.

2. The method according to claim 1 , wherein the treatment reduces bad breath.

3. The method according to claim 1 , wherein said oral composition is exposed to actinic light for a period of less than about 5 minutes.

4. The method according to claim 1 , wherein said oral composition is exposed to actinic light for a period of about 60 seconds to about 5 minutes.

5. The method according to claim 1 , wherein said oral composition is exposed to actinic light for a period of less than about 5 minutes per cm 2 of an area to be treated.

6. The method according to claim 1 , wherein said oral composition is exposed to actinic light for a period of about 60 seconds to about 5 minutes per cm 2 of an area to be treated.

7. The method according to claim 1 , wherein said oral tissue comprises a gingiva or a portion thereof.

8. The method according to claim 1 , wherein said oral tissue is on or near at least one tooth.

9. The method according to claim 8 , wherein said oral tissue that is near at least one tooth is exposed to actinic light for a period of about at least 10 seconds on a vestibular side, and of about at least 10 seconds on a oral side.

10. The method according to claim 1 , wherein the oxidant is selected from hydrogen peroxide, carbamide peroxide and benzoyl peroxide.

11. The method according to claim 1 , wherein the composition further comprises at least one hydrophilic gelling agent.

12. The method according to claims 11 , wherein the hydrophilic gelling agent is selected from glucose, modified starch, methyl cellulose, carboxymethyl cellulose, propyl cellulose, hydroxypropyl cellulose, carbomer polymers, alginic acid, sodium alginate, potassium alginate, ammonium alginate, calcium alginate, agar, carrageenan, locust bean gum, pectin, and gelatin.

13. The method according to claim 1 , wherein the composition further comprises a xanthene derivative dye, an azo dye, a biological stain, or a carotenoid.

14. The method according to claim 1 , wherein said composition further comprises at least one chelating agent selected from ethylenediaminetetraacetic acid (EDTA) and ethylene glycol tetraacetic acid (EGTA).

15. The method according to claim 1 , wherein the composition further comprises at least one of: phloxine B, rose bengal, merbromine, eosin B, fluorescein, erythrosine B, saffranin O, saffron red powder, annatto extract, brown algae extract, basic fuchsin, acid fuschin, 3,3′ dihexylocarbocyanine iodide, carminic acid, indocyanine green, crocetin, α-crocin (8,8-diapo-8,8-carotenoic acid), zeaxanthine, lycopene, α-carotene, β-carotene, bixin, fucoxanthine, methyl violet, neutral red, para red, amaranth, carmoisine, allura red AC, tartrazine, orange G, ponceau 4R, methyl red, murexide-ammonium purpurate, pyronine Y and pyronine B.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2023
From: KLOX TECHNOLOGIES INC.
To: FLE INTERNATIONAL S.R.L.
Reel/Frame 063214/0370 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2019
From: PIERGALLINI, REMIGIO; LOUPIS, NIKOLAOS
To: KLOX TECHNOLOGIES INC.
Reel/Frame 050960/0441 →
Continuity (7)
Continuation 16413683 · May 16, 2019
Continuation 15433545 · Feb 15, 2017
Continuation 14539310 · Nov 12, 2014
Continuation 14137666 · Dec 20, 2013
Continuation 13387328
Provisional Application 61226354 · Jul 17, 2009
Related Publication 20200138949A1 · May 7, 2020